Suchergebnisse - "Sperduti, Isabella"

PubPharm (21)

1

T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients : a meta-analysis

enthalten in: BMC cancer | 2022

von Omarini, C. | Piacentini, F. | Sperduti, I. | +8

2

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

enthalten in: Scientific reports | 2021

von Pizzuti, L. | Barba, M. | Mazzotta, M. | +53

3

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade : the SePHER Study

enthalten in: Journal of experimental & clinical cancer research : CR | 2020

von Bon, G. | Pizzuti, L. | Laquintana, V. | +50

4

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

enthalten in: Journal of cellular physiology | 2020

von Krasniqi, E. | Pizzuti, L. | Barchiesi, G. | +65

5

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer : to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials

enthalten in: BMC cancer | 2020

von Omarini, C. | Piacentini, F. | Sperduti, I. | +7

6

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

enthalten in: International journal of cancer | 2020

von Pizzuti, L. | Krasniqi, E. | Barchiesi, G. | +83

7

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer : A real-world experience

enthalten in: Journal of cellular physiology | 2019

von Pizzuti, L. | Giordano, A. | Michelotti, A. | +65

8

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab

enthalten in: Cancer biology & therapy | 2018

von Pizzuti, L. | Sergi, D. | Sperduti, I. | +30

9

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer

enthalten in: Journal of cellular physiology | 2017

von Gamucci, T. | Mentuccia, L. | Natoli, C. | +28

10

Discordance in pathology report after central pathology review : Implications for breast cancer adjuvant treatment

enthalten in: Breast (Edinburgh, Scotland) | 2016

von Orlando, L. | Viale, G. | Bria, E. | +10